Viral pneumonia (unknown virus, not influenza)

VIRALPNEUMONAS

viral pneumonia: Inflammation of the lung parenchyma that is caused by a viral infection.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J12.8, J12.9 Hospital discharge: ICD-9 — 480 Hospital discharge: ICD-8 — 480 Hospital discharge: excluded ICD-9 — 480[0-2] Cause of death: ICD-10 — J12.8, J12.9 Cause of death: ICD-9 — 480 Cause of death: ICD-8 — 480 Cause of death: excluded ICD-9 — 480[0-2] 2 out of 7 registries used, show all original rules.	2674
4. Check minimum number of events None	2674
5. Include endpoints None	2674
6. Filter based on genotype QC (FinnGen only)	2674

Control definitions (FinnGen only)

Control exclude: ASTHMA_PNEUMONIA

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	VIRALPNEUMONAS
CONTROL_EXCLUDE	ASTHMA_PNEUMONIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J128\|J129
HD_ICD_9	480
HD_ICD_8	480
HD_ICD_10_EXCL
HD_ICD_9_EXCL	480[0-2]
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J128\|J129
COD_ICD_9	480
COD_ICD_8	480
COD_ICD_10_EXCL
COD_ICD_9_EXCL	480[0-2]
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Viral pneumonia (unknown virus, not influenza) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	22206	9354	12641
Only index persons	17921	7501	10420
Unadjusted period prevalence (%)
Whole population	0.32	0.27	0.35
Only index persons	0.35	0.28	0.40
Median age at first event (years)
Whole population	26.87	35.15	20.24
Only index persons	21.48	24.06	19.62

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2674	1247	1427
Unadjusted period prevalence (%)	0.53	0.43	0.63
Median age at first event (years)	52.21	48.37	55.57

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2327: Matched controls
23279

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

48099

ICD-8 Finland

Viral pneumonia

+∞

323.0

309

J12.8

ICD-10 Finland

Other viral pneumonia

4202.5

323.0

1045

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

8.8

323.0

1203

2533

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

2470.0

323.0

680

4809X

ICD-9 Finland

Viral pneumonia, unspecified

+∞

249.5

235

J18.9

ICD-10 Finland

Pneumonia, unspecified

5.2

228.5

870

2382

XF400

NOMESCO Finland

ECG with 12 standard connections

3.1

74.7

484

1826

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.0

74.0

516

2045

J45.9

ICD-10 Finland

Asthma, unspecified

3.1

72.3

468

1762

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

4.5

70.1

270

662

4808X

ICD-9 Finland

Viral pneumonia, Pneumonia due to other virus not elsewhere classified

+∞

69.1

R4110

NOMESCO Finland

Physiotherapy

2.4

67.9

706

3513

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

21.3

67.1

100

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

5.8

66.4

199

369

R03AC02

ATC

salbutamol; inhalant

2.1

64.8

1247

8212

H02AB06

ATC

prednisolone; systemic

2.1

62.0

1083

6795

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.9

59.9

424

1675

Z29.8

ICD-10 Finland

Other specified prophylactic measures

7.0

54.5

140

211

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

52.4

966

6060

C03CA01

ATC

furosemide; systemic

2.3

52.1

584

2950

R06.0

ICD-10 Finland

Dyspnoea

2.3

50.3

575

2924

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

49.4

518

2523

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.3

44.5

247

814

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.5

43.3

219

674

R50.9

ICD-10 Finland

Fever, unspecified

2.5

42.6

387

1736

J45.1

ICD-10 Finland

Nonallergic asthma

3.8

42.4

190

529

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

42.2

1079

7435

R03BA02

ATC

budesonide; inhalant

2.4

42.2

421

1982

R83

ICPC

Respiratory infection other

2.0

40.9

669

3912

ZXD10

NOMESCO Finland

Scheduled procedure

1.9

40.6

855

5485

ZXE00

NOMESCO Finland

One hour or less

1.8

39.7

914

6040

Z2221

NOMESCO Finland

Medical doctor

2.0

39.1

667

3951

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.3

38.8

433

2145

U08.9

ICD-10 Finland

Personal history of COVID-19, unspecified

21.6

38.8

L04AA06

ATC

mycophenolic acid; systemic

7.7

38.7

124

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.5

38.5

190

573

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

37.4

804

5160

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.8

37.2

257

981

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.5

36.0

308

1330

R03BB04

ATC

tiotropium bromide; inhalant

3.0

34.7

219

787

127

Kela drug reimbursment

Transplant complication

7.4

33.8

114

R03DC03

ATC

montelukast; oral

2.3

33.2

358

1733

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.0

32.8

204

726

R03AC03

ATC

terbutaline; inhalant

2.3

32.6

336

1591

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

31.9

1143

8468

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

7.5

31.7

104

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.0

31.7

191

665

J01MA12

ATC

levofloxacin; systemic

2.1

31.7

402

2089

J45

ICD-10 Finland

Asthma

2.7

31.6

233

923

R03AK07

ATC

formoterol and budesonide; inhalant

2.1

31.2

424

2267

R02

ICPC

Shortness of breath/dyspnoea

2.5

30.9

268

1162

R03DA04

ATC

theophylline; systemic, rectal

4.1

30.7

125

319

ZX120

NOMESCO Finland

Intravenous

2.6

30.4

235

956

J01FA06

ATC

roxithromycin; oral

1.7

29.7

837

5746

TGC00

NOMESCO Finland

Bronchial lavation

5.4

29.7

173

J01MA14

ATC

moxifloxacin; systemic

2.8

29.7

210

809

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

29.2

594

3677

Z3231

NOMESCO Finland

Registered nurse

1.8

29.1

612

3831

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.7

29.1

132

371

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

28.2

362

1885

A02BC02

ATC

pantoprazole; systemic

1.6

28.1

1316

10337

WX726

NOMESCO Finland

High-flow oxygen therapy

78.6

27.8

J46

ICD-10 Finland

Status asthmaticus

6.7

27.5

109

N02AX02

ATC

tramadol; systemic, rectal

1.7

27.2

851

5979

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.5

26.8

152

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

9.2

26.7

R03BA05

ATC

fluticasone; inhalant

2.0

26.7

406

2259

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.7

26.2

189

734

TK800

NOMESCO Finland

Hemodialysis

5.2

26.2

165

Z3226

NOMESCO Finland

Physiotherapist

1.9

26.1

410

2306

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

7.5

26.0

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.2

25.8

159

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

4.3

25.7

231

I50.9

ICD-10 Finland

Heart failure, unspecified

2.3

25.7

250

1143

ZXD05

NOMESCO Finland

Urgent procedure

1.7

25.5

688

4614

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

5.3

25.2

151

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.2

24.4

134

438

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.3

23.6

121

376

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

23.6

562

3623

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.4

23.4

202

871

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

23.2

298

1545

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.4

23.2

116

354

ZX108

NOMESCO Finland

Inhalation

12.6

23.1

XF600

NOMESCO Finland

Bloodpressure measurement

2.7

22.9

159

606

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.9

22.7

143

513

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.2

22.7

258

1268

J01FF01

ATC

clindamycin; systemic

1.7

22.7

568

3706

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

5.0

22.6

153

WX892

NOMESCO Finland

Monitored bed care

2.5

22.3

179

741

GD1AD

NOMESCO Finland

Thorax CT examination

3.4

22.2

111

339

H02AB07

ATC

prednisone; oral

2.1

22.0

285

1480

R81

ICPC

Pneumonia

4.1

21.9

219

J01CA04

ATC

amoxicillin; systemic

1.6

21.6

1795

15712

R60.0

ICD-10 Finland

Localized oedema

2.3

21.2

216

1009

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.7

21.1

150

580

WX730

NOMESCO Finland

Conventional respirator

5.5

20.9

115

J01DB01

ATC

cefalexin; oral

1.6

20.8

1791

15717

A46

ICD-10 Finland

Erysipelas

2.0

20.6

283

1505

N03AX16

ATC

pregabalin; oral

1.7

20.5

460

2890

J01AA02

ATC

doxycycline; systemic

1.5

20.5

1600

13671

WX110

NOMESCO Finland

Local anesthesy

1.5

20.5

1504

12678

B34.2

ICD-10 Finland

Coronavirus infection, unspecified site

11.3

20.4

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

20.3

332

1882

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.2

20.1

107

343

A28

ICPC

Limited function/disability NOS

2.1

19.9

255

1316

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

4.0

19.9

204

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

19.6

283

1531

Z94.0

ICD-10 Finland

Kidney transplant status

6.5

19.6

J45.8

ICD-10 Finland

Mixed asthma

4.2

19.5

179

AA1AD

NOMESCO Finland

CT of head and brain

1.7

19.4

444

2806

Z71.8

ICD-10 Finland

Other specified counselling

1.7

19.4

516

3404

Z29.0

ICD-10 Finland

Isolation

15.7

19.3

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.0

19.2

R03AC12

ATC

salmeterol; inhalant

3.3

19.0

296

C07AB07

ATC

bisoprolol; oral

1.5

18.9

822

6123

A41.9

ICD-10 Finland

Sepsis, unspecified

3.6

18.9

244

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

18.9

216

1062

TKC20

NOMESCO Finland

Catheterisation of bladder

2.5

18.9

155

650

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.1

18.8

105

348

J01FA10

ATC

azithromycin; systemic

1.5

18.7

1253

10250

L28

ICPC

Limited function/disability (L)

1.9

18.6

279

1532

R53

ICD-10 Finland

Malaise and fatigue

1.7

18.5

422

2660

R05

ICPC

Cough

1.7

18.3

445

2856

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

18.2

531

3581

WX402

NOMESCO Finland

General anaesthesia

1.8

18.2

349

2081

H02AB04

ATC

methylprednisolone; systemic

1.9

18.1

278

1537

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.3

17.9

282

A11CC03

ATC

alfacalcidol; systemic

4.3

17.8

156

J01MA02

ATC

ciprofloxacin; systemic

1.5

17.8

751

5541

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.4

17.8

158

691

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

8.2

17.7

WX110

SPAT

2.7

17.7

121

458

A03

ICPC

Fever

1.7

17.5

369

2266

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

17.4

214

1085

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

7.9

17.3

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

17.1

445

2905

WX002

NOMESCO Finland

Sedation and analgesia

1.7

17.1

381

2378

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

17.0

275

1550

I50.0

ICD-10 Finland

Congestive heart failure

2.6

16.9

124

489

N18.0

ICD-10 Finland

End-stage renal disease

6.4

16.9

B01AB05

ATC

enoxaparin; parenteral

1.6

16.7

550

3813

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.5

16.7

B03XA02

ATC

darbepoetin alfa; parenteral

4.8

16.7

116

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

16.5

468

3124

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

16.5

504

3432

XW000

NOMESCO Finland

Bone marrow biopsy

2.9

16.5

100

351

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

3.7

16.4

199

N02BE01

ATC

paracetamol; systemic, rectal

1.5

16.4

1796

16038

A12AA04

ATC

calcium carbonate; oral

5.2

16.2

E66.8

ICD-10 Finland

Other obesity

2.6

16.2

116

452

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

16.1

134

566

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.5

16.0

219

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.2

16.0

262

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

4.1

15.9

155

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

15.8

366

2307

Z2446

NOMESCO Finland

Social worker

2.2

15.8

160

746

R03BB01

ATC

ipratropium bromide; inhalant

3.5

15.8

222

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

6.3

15.6

A06AD11

ATC

lactulose; oral

1.9

15.6

255

1440

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

15.5

905

7094

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

4.9

15.5

103

R03BA01

ATC

beclometasone; inhalant

1.9

15.5

252

1419

N18.8

ICD-10 Finland

Other chronic renal failure

3.6

15.5

194

J20

ICD-10 Finland

Acute bronchitis

2.1

15.4

182

906

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

15.4

401

2613

49300

ICD-8 Finland

Asthma, bronchiale

4.3

15.4

136

J01DA01

ATC

[U] cefalexin; systemic

1.4

15.3

1291

10850

C08CA01

ATC

amlodipine; oral

1.5

15.3

608

4396

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

6.1

15.3

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

8.3

15.2

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

15.2

981

7832

J01FA09

ATC

clarithromycin; systemic

1.5

15.1

623

4538

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.4

15.1

224

R03AC13

ATC

formoterol; inhalant

2.9

15.1

330

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

15.1

382

2464

WW200

NOMESCO Finland

Immunization

3.1

14.8

266

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.1

14.8

167

815

J96.1

ICD-10 Finland

Chronic respiratory failure

4.4

14.4

121

L04AX01

ATC

azathioprine; systemic

2.6

14.4

106

421

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.6

14.3

108

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

14.3

187

972

TK810

NOMESCO Finland

Hemofiltration

8.2

14.3

R06AE07

ATC

cetirizine; oral

1.4

14.1

874

6895

R51.80

ICD-10 Finland

Headache

1.7

14.1

304

1875

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

14.0

844

6620

ZXA00

NOMESCO Finland

Right side

1.5

14.0

488

3412

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

8.9

14.0

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.7

13.9

354

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

13.9

686

5174

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.3

13.8

129

580

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

13.8

756

5817

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

13.7

202

1097

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.6

13.6

409

2757

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

13.6

657

4928

M10.9

ICD-10 Finland

Gout, unspecified

2.3

13.6

124

549

G47.3

ICD-10 Finland

Sleep apnoea

1.6

13.6

420

2853

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

13.6

384

2548

R03AK11

ATC

formoterol and fluticasone; inhalant

3.5

13.5

179

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

13.5

127

572

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

13.4

148

717

J96.0

ICD-10 Finland

Acute respiratory failure

5.3

13.3

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.9

13.3

292

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

13.3

352

2295

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

13.2

139

660

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

6.5

13.1

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

10.1

13.0

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

12.9

162

830

J01DA06

ATC

[U] cefuroxime; systemic

1.7

12.8

286

1780

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

12.8

550

4021

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

12.7

432

2997

R03AK08

ATC

formoterol and beclometasone; inhalant

3.0

12.7

249

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.2

12.6

123

566

A02BC05

ATC

esomeprazole; systemic

1.4

12.5

731

5672

M79.6

ICD-10 Finland

Pain in limb

1.4

12.5

654

4969

M04AA01

ATC

allopurinol; systemic

1.8

12.5

225

1310

H02AB09

ATC

hydrocortisone; systemic

3.4

12.5

181

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.2

12.4

125

583

WW500

NOMESCO Finland

Blood transfusion

2.7

12.4

313

GD2SN

NOMESCO Finland

Lung ventilation SPECT

8.0

12.3

C08CA02

ATC

felodipine; oral

2.0

12.3

151

767

B01AB10

ATC

tinzaparin; parenteral

2.1

12.1

131

629

XG410

NOMESCO Finland

Flow-volume spirometry

2.7

12.1

324

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

8.7

12.0

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

12.0

466

3330

ZXD20

NOMESCO Finland

Day surgery

1.7

11.9

244

1480

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

13.4

11.9

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

1.8

11.9

202

1155

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

4.3

11.8

102

GD1UN

NOMESCO Finland

Lung circulation SPECT

8.4

11.8

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

11.8

199

1134

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.5

11.7

158

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.8

11.6

258

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

4.9

11.6

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

6.2

11.5

A02BC01

ATC

omeprazole; systemic

1.5

11.4

486

3533

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

11.4

227

1365

R03BC01

ATC

cromoglicic acid; inhalant

3.8

11.3

126

J01FA01

ATC

erythromycin; systemic

1.6

11.3

299

1946

V03AE02

ATC

sevelamer; oral

8.3

11.3

EB1AA

SPAT

2.3

11.2

103

460

R01AD08

ATC

fluticasone; nasal

1.4

11.2

535

3980

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

4.5

11.1

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

11.1

203

1189

ZXA05

NOMESCO Finland

Left side

1.5

11.0

433

3093

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

11.0

493

3619

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

10.9

551

4137

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

10.9

463

3361

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.3

10.9

441

JN4AD

NOMESCO Finland

Body CT examination

2.0

10.9

134

681

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.5

10.8

R04.2

ICD-10 Finland

Haemoptysis

2.9

10.8

239

WX723

NOMESCO Finland

CPAP therapy

2.6

10.8

314

JN4BD

NOMESCO Finland

Extensive body CT

1.8

10.7

192

1116

WX872

NOMESCO Finland

Intensive care

2.3

10.7

102

463

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

10.7

386

2707

48609

ICD-8 Finland

Pneumonia, unspecified

3.8

10.6

114

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

10.6

169

947

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.0

10.5

133

682

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.2

10.5

167

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

10.5

565

4292

B01AA03

ATC

warfarin; systemic

1.6

10.5

308

2055

R05FB02

ATC

cough suppressants and expectorants

1.4

10.5

652

5083

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.9

10.4

212

R03CC02

ATC

salbutamol; systemic

1.9

10.4

149

802

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

5.2

10.4

J18.2

ICD-10 Finland

Hypostatic pneumonia, unspecified

+∞

10.4

J128, U071

ICD-10 Finland

+∞

10.4

R03BA08

ATC

ciclesonide; inhalant

1.9

10.4

143

759

C09AA05

ATC

ramipril; oral

1.5

10.3

389

2748

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

10.3

162

903

R05

ICD-10 Finland

Cough

1.5

10.3

335

2290

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

6.4

10.3

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.6

10.2

123

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.1

10.2

116

573

A10AE04

ATC

insulin glargine; parenteral

1.8

10.1

178

1030

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.2

10.1

438

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

10.0

367

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.9

10.0

105

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

9.9

141

757

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

9.9

185

1089

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

9.9

205

1245

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.6

9.9

121

R42

ICD-10 Finland

Dizziness and giddiness

1.5

9.8

353

2469

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

4.1

9.8

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.4

9.8

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

6.0

9.8

Z94.2

ICD-10 Finland

Lung transplant status

20.1

9.8

U08

ICD-10 Finland

Personal history of COVID-19

9.6

9.8

WX722

NOMESCO Finland

PEEP

2.3

9.6

407

N19

ICD-10 Finland

Unspecified kidney failure

2.8

9.6

216

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

9.6

161

916

R4190

NOMESCO Finland

Nutritional therapy

2.5

9.5

311

XG466

NOMESCO Finland

Sleep oxymetry

2.6

9.5

267

J15.8

ICD-10 Finland

Other bacterial pneumonia

7.2

9.5

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.2

9.5

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

9.4

131

698

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

9.4

229

1458

48009

ICD-8 Finland

+∞

9.4

L04AD01

ATC

ciclosporin; systemic

3.2

9.4

154

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.8

9.3

146

813

L03AA02

ATC

filgrastim; parenteral

3.0

9.3

180

UKC02

NOMESCO Finland

Cystoscopy

1.6

9.3

270

1796

Z49.0

ICD-10 Finland

Preparatory care for dialysis

5.2

9.2

R96

ICPC

Asthma

1.9

9.2

135

735

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

2.4

9.1

307

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

9.1

437

3237

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

9.1

101

493

Z01.7

ICD-10 Finland

Laboratory examination

1.6

9.1

212

1333

L04AA01

ATC

[U] ciclosporin; systemic

3.8

9.0

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.8

9.0

193

N05BA01

ATC

diazepam; systemic, rectal

1.6

9.0

240

1565

I50.1

ICD-10 Finland

Left ventricular failure

2.4

8.9

316

GDG10

NOMESCO Finland

Bilateral transplantation of lung

24.1

8.9

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

8.9

303

2092

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

8.9

151

865

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

4.2

8.9

J01CF05

ATC

flucloxacillin; systemic

2.3

8.8

350

UJF32

NOMESCO Finland

Coloscopy

1.4

8.8

419

3096

Z94.1

ICD-10 Finland

Heart transplant status

10.7

8.8

137

Kela drug reimbursment

Uraemia requiring dialysis

4.6

8.8

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

8.7

490

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

5.6

8.7

B01AF02

ATC

apixaban; oral

1.8

8.7

142

802

X58

ICD-10 Finland

Exposure to other specified factors

1.5

8.7

278

1893

SPAT1324

SPAT

Screening procedure

0.6

8.7

118

1963

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

8.6

185

1137

H66.9

ICD-10 Finland

Otitis media, unspecified

1.9

8.6

129

709

J05AB01

ATC

aciclovir; systemic

1.5

8.6

364

2630

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.8

8.6

145

831

EBA05

SPAT

4.0

8.5

R03DC01

ATC

zafirlukast; oral

3.9

8.5

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

8.5

139

788

C90.0

ICD-10 Finland

Multiple myeloma

4.4

8.4

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.9

8.3

166

ZY010

NOMESCO Finland

Hospital outpatient

2.0

8.3

110

575

WVA20

NOMESCO Finland

Medicine administration

2.8

8.3

180

S06.0

ICD-10 Finland

Concussion

1.6

8.3

191

1199

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.9

8.2

111

588

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.8

8.2

176

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

8.1

362

2643

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

8.1

211

1369

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

11.7

8.1

R06.2

ICD-10 Finland

Wheezing

2.2

8.1

388

3829X

ICD-9 Finland

Suppurative and unspecified otitis media, Unspecified otitis media

10.1

8.0

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

8.0

147

864

B05DB

ATC

Hypertonic solutions

6.3

8.0

R33

ICD-10 Finland

Retention of urine

1.8

8.0

129

727

ZXA10

NOMESCO Finland

Bilateral

1.5

8.0

305

2159

N05BA04

ATC

oxazepam; oral

1.4

7.9

431

3260

E0000UV

ATC

1.3

7.9

741

6109

S97

ICPC

Chronic ulcer skin

2.1

7.9

434

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

6.6

7.9

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.3

7.8

312

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

7.8

441

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.8

7.8

176

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

4.2

7.8

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.7

7.8

150

895

L04AX04

ATC

lenalidomide; oral

7.0

7.8

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

7.7

313

2243

R74

ICPC

Upper respiratory infection acute

1.3

7.6

575

4586

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

7.6

277

1937

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

2.9

7.6

153

R11

ICD-10 Finland

Nausea and vomiting

1.7

7.6

152

915

WX320

NOMESCO Finland

Spinalanesthesy

1.4

7.6

372

2761

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

7.6

303

2161

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

7.6

160

979

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.4

7.6

100

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

7.6

405

K02.1

ICD-10 Finland

Caries of dentine

1.3

7.6

1173

10319

R01AD09

ATC

mometasone; nasal

1.3

7.5

842

7099

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

8.9

7.5

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.4

7.5

101

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

4.7

7.5

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.5

7.5

211

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

7.5

218

1455

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.6

7.4

B34.9

ICD-10 Finland

Viral infection, unspecified

2.4

7.4

260

153

Kela drug reimbursment

Lenalidomid

6.5

7.4

N02AA05

ATC

oxycodone; systemic

1.6

7.4

214

1424

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

13.4

7.4

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

7.4

179

1142

J47

ICD-10 Finland

Bronchiectasis

3.8

7.3

N03AX12

ATC

gabapentin; oral

1.5

7.3

254

1762

U09

ICD-10 Finland

Post COVID-19 condition

4.3

7.3

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

4.3

7.3

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.9

7.3

104

562

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

6.8

7.3

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

7.2

142

853

N30.0

ICD-10 Finland

Acute cystitis

1.5

7.2

220

1482

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

7.2

138

820

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

7.2

140

838

J02AC03

ATC

voriconazole; systemic

15.8

7.2

46599

ICD-8 Finland

Acute upper respiratory infection of multiple or unspecified sites

1.8

7.2

115

648

V03AE03

ATC

lanthanum carbonate; oral

7.3

7.2

J43.9

ICD-10 Finland

Emphysema, unspecified

4.1

7.2

J02AC01

ATC

fluconazole; systemic

1.3

7.2

659

5405

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

7.2

501

7AX01

NOMESCO Finland

30.1

7.1

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

7.1

215

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

12.0

7.1

M25.5

ICD-10 Finland

Pain in joint

1.3

7.1

491

3865

Z49.2

ICD-10 Finland

Other dialysis

4.5

7.1

A41.8

ICD-10 Finland

Other specified sepsis

3.6

7.1

EBA00

NOMESCO Finland

Extraction of tooth

1.3

7.0

635

5190

N06AX11

ATC

mirtazapine; oral

1.3

7.0

557

4471

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.7

7.0

175

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

7.0

236

1625

J01DC02

ATC

cefuroxime; systemic

1.9

7.0

104

572

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.1

7.0

355

B05DA

ATC

Isotonic solutions

4.7

7.0

C03DA01

ATC

spironolactone; oral

1.6

7.0

156

973

WX290

SPAT

2.4

7.0

238

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

7.0

332

2451

N17.8

ICD-10 Finland

Other acute renal failure

4.0

7.0

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.0

7.0

394

196

Kela drug reimbursment

Paricalcitol and cinacalcet

5.8

6.9

M01AB05

ATC

diclofenac; systemic, rectal

1.3

6.9

1265

11307

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

6.9

229

1573

ZXD35

NOMESCO Finland

Usual procedure

2.2

6.9

304

R06AX27

ATC

desloratadine; oral

1.3

6.9

505

4006

R4120

NOMESCO Finland

Occupational therapy

1.8

6.9

112

633

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

6.9

101

555

1240

FHL

Bronchoscopy

4.4

6.8

L17

ICPC

Foot/toe symptom/complaint

1.4

6.8

411

3162

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

6.8

711

5929

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.0

6.8

121

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

6.1

6.8

A23

ICPC

Risk factor NOS

1.6

6.8

155

971

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

6.7

147

910

5AB14

NOMESCO Finland

16.7

6.7

WX780

NOMESCO Finland

Remote monitoring CPAP

2.1

6.7

348

K07

ICPC

Swollen ankles/oedema

2.2

6.7

280

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.2

6.7

314

V03AE01

ATC

polystyrene sulfonate; oral

3.5

6.7

XF404

NOMESCO Finland

Ambulatory ECG

1.6

6.6

151

947

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

5.2

6.6

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.2

6.6

101

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.4

6.6

214

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.9

6.6

133

M10

ICD-10 Finland

Gout

2.0

6.6

369

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

6.6

125

743

A08

ICPC

Swelling

2.2

6.5

287

WX290

NOMESCO Finland

Other blockade of nerve

1.3

6.5

912

7873

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.2

6.5

267

B01AC04

ATC

clopidogrel; oral

1.5

6.5

223

1539

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.6

6.5

151

951

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.1

6.5

336

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.0

6.5

377

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

5.3

6.5

R52.0

ICD-10 Finland

Acute pain

2.2

6.4

282

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

5.7

6.4

N05CF01

ATC

zopiclone; oral

1.3

6.4

528

4251

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

70.0

6.4

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.1

6.4

109

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

6.4

110

638

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

3.1

6.4

104

K65.0

ICD-10 Finland

Acute peritonitis

3.6

6.4

N03AX14

ATC

levetiracetam; systemic

2.4

6.4

224

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

3.8

6.4

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.8

6.4

138

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

6.3

373

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.7

6.3

154

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

8.2

6.3

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.4

6.3

347

2624

U14

ICPC

Kidney symptom/complaint

3.4

6.3

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

6.3

154

985

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

6.3

363

2769

R4180

NOMESCO Finland

Podiatric therapy

4.0

6.3

N05BB01

ATC

hydroxyzine; systemic

1.7

6.3

114

671

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

6.3

270

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

6.3

121

727

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.0

6.3

391

48000

ICD-8 Finland

+∞

6.2

J01DA08

ATC

[U] cefaclor; oral

1.5

6.2

235

1655

N17

ICPC

Vertigo/dizziness

1.6

6.2

170

1114

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

6.2

188

1263

N05AH04

ATC

quetiapine; oral

1.4

6.2

310

2304

J20.6

ICD-10 Finland

Acute bronchitis due to rhinovirus

26.7

6.2

S76

ICPC

Skin infection other

1.9

6.2

449

R5110

SPAT

2.6

6.2

174

B01AB04

ATC

dalteparin; parenteral

1.9

6.2

435

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

6.2

368

2821

M05BX04

ATC

denosumab; parenteral

2.1

6.2

308

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

6.2

199

1358

C09AA02

ATC

enalapril; systemic

1.4

6.2

300

2221

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.8

6.2

128

A10AE05

ATC

insulin detemir; parenteral

1.8

6.1

102

583

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

7.7

6.1

4659X

ICD-9 Finland

Acute upper respiratory infections of multiple or unspecified sites, Unspecified site

2.2

6.1

256

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

12.5

6.1

A10BH01

ATC

sitagliptin; oral

1.6

6.0

140

881

XF622

NOMESCO Finland

Measurement of minute volume of heart

8.6

6.0

A49

ICD-10 Finland

Bacterial infection of unspecified site

8.6

6.0

J43.2

ICD-10 Finland

Centrilobular emphysema

8.6

6.0

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

4.9

6.0

Z73.6

ICD-10 Finland

Limitation of activities due to disability

4.9

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

473

715

7.82

307.89

2.7

2.0

ug/l

1.2

2.1

0.68

441

632

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1413

4454

5.61

307.65

3.7

1.8

mg/l

1.3

1.1

1.71

1259

3298

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

525

617

10.34

307.65

3.0

2.9

g/l

4.9

3.5

43.38

520

583

(3023368) Bacteria identified in Blood by Culture

1519

5110

5.57

307.65

7.1

4.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

991

2992

4.67

302.99

2.7

1.8

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

992

3121

4.46

284.94

5.2

3.6

mmol/l

0.8

0.39

967

2935

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

788

2127

4.84

274.81

5.3

4.3

u/l

264.6

242.2

3.53

774

2013

(42870588) Differential panel, method unspecified - Blood

1543

6913

3.91

262.78

10.2

6.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

743

2050

4.63

249.77

2.4

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

745

2074

4.59

247.36

2.4

1.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

645

1680

4.74

231.83

18.7

7.7

mmol/l

1.3

1.4

2.46

633

1614

(3022096) Basophils/100 leukocytes in Blood

1792

9404

3.75

228.47

10.8

6.0

0.5

0.7

35.64

1756

8818

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

463

953

5.67

218.78

23.1

10.7

mmol/l

24.8

24.1

3.93

448

909

(3000991) Gas panel - Venous blood

613

1602

4.67

218.44

21.4

9.1

—

(3006504) Eosinophils/100 leukocytes in Blood

1807

9708

3.66

218.05

10.9

6.0

2.1

2.8

41.64

1770

9080

(3019069) Monocytes/100 leukocytes in Blood

1807

9765

3.63

214.73

11.1

6.2

8.2

8.6

4.88

1774

9187

(3006315) Basophils [#/volume] in Blood

1856

10366

3.59

205.46

10.3

5.8

e9/l

0.0

2.78

1559

9016

(3001604) Monocytes [#/volume] in Blood

1852

10336

3.58

205.13

10.3

5.8

e9/l

0.6

3.12

1556

8988

(3002030) Lymphocytes/100 leukocytes in Blood

1821

10103

3.52

202.65

11.0

6.0

24.2

28.6

43.38

1787

9465

(3018010) Neutrophils/100 leukocytes in Blood

1803

9950

3.49

202.25

10.5

5.8

61.6

56.7

48.41

1770

9358

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

967

3694

3.53

198.94

4.9

3.5

ng/l

346.3

486.2

0.61

785

2721

(3013115) Eosinophils [#/volume] in Blood

1875

10707

3.52

196.46

11.2

6.1

e9/l

0.2

6.13

1594

9472

(3019198) Lymphocytes [#/volume] in Blood

1872

10689

3.51

195.96

10.3

5.9

e9/l

2.0

1.9

0.35

1601

9482

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

124

26.49

179.00

1.4

1.1

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

666

2120

3.85

178.59

19.5

8.0

kpa

5.0

5.1

0.43

645

2033

(3020779) Urea [Moles/volume] in Serum or Plasma

595

1752

4.08

178.29

13.1

7.8

mmol/l

9.8

9.2

1.17

584

1684

(3027801) Oxygen [Partial pressure] in Arterial blood

665

2120

3.84

177.87

19.4

8.0

kpa

10.6

12.7

26.17

642

2033

(3003396) Base excess in Arterial blood by calculation

665

2124

3.84

177.33

18.9

8.0

mmol/l

1.1

0.9

0.52

568

1637

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

108

35.13

170.92

1.4

1.2

ng/l

97.5

111.1

0.07

(3013650) Neutrophils [#/volume] in Blood by Automated count

1936

11940

3.25

164.45

15.5

8.9

e9/l

4.4

4.1

6.82

1662

10444

(3033658) Prothrombin time (PT) actual/Normal

1100

5132

2.94

153.48

7.3

4.0

91.4

90.4

0.62

1085

5001

(3006184) Hemoglobin [Mass/volume] in Capillary blood

250

400

6.79

151.39

3.7

2.3

g/l

127.5

131.3

1.12

189

311

(3021901) Oxygen saturation in Capillary blood

230

344

7.22

148.30

5.4

2.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

302

594

5.60

147.97

3.8

3.3

u/ml

0.3

0.61

151

337

(3003458) Phosphate [Moles/volume] in Serum or Plasma

694

2548

3.33

146.36

10.8

6.2

mmol/l

1.1

1.0

1.31

675

2377

(3014576) Chloride [Moles/volume] in Serum or Plasma

661

2394

3.34

142.13

20.6

7.2

mmol/l

104.4

104.5

0.08

646

2333

(3016502) Oxygen saturation in Arterial blood

573

1916

3.53

139.75

21.8

8.4

94.1

95.9

7.87

557

1849

(3028626) Oxygen [Partial pressure] in Capillary blood

264

489

5.88

137.73

5.9

4.2

kpa

8.1

8.5

2.49

250

456

(3015235) Bicarbonate [Moles/volume] in Capillary blood

260

477

5.93

137.00

6.5

3.2

mmol/l

24.9

24.8

0.16

236

420

(3021589) Normoblasts [#/volume] in Blood

1576

9253

2.71

135.67

18.5

8.9

e9/l

0.0

0.64

1212

7582

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

405

1090

4.20

135.07

2.0

1.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

437

1245

4.00

134.75

6.3

4.1

kpa

5.1

0.77

420

1159

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1681

10238

2.73

133.60

11.2

6.1

umol/l

10.2

11.8

8.44

1621

9726

(3009343) pH of Capillary blood

431

1229

3.99

132.62

6.3

4.1

7.4

3.51

132

146

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

250

457

5.93

132.14

2.4

1.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

421

1189

4.02

131.24

6.1

4.1

mmol/l

2.2

1.6

2.65

351

879

(1616796) Gas panel - Central venous blood

237

416

6.15

130.61

6.7

3.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1559

9233

2.65

129.73

4.1

2.7

ug/l

322.1

119.8

40.92

1511

8593

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1586

9474

2.66

129.61

17.3

6.7

mmol/l

1.2

19.49

1409

8021

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1484

8607

2.63

128.54

16.4

6.1

mmol/l

1.2

20.63

1408

7826

(3002173) Hemoglobin [Mass/volume] in Arterial blood

531

1777

3.48

128.53

23.0

8.7

g/l

122.6

123.6

0.46

518

1714

(40767503) Oxygen content in Capillary blood by calculation

228

393

6.25

127.94

5.0

2.4

16.0

16.6

1.18

165

203

(3030467) Casts [#/volume] in Urine by Automated count

1090

5461

2.68

127.39

4.8

3.0

e6/l

0.4

0.17

812

4091

(3014007) Fractional oxyhemoglobin in Arterial blood

412

1177

3.96

126.13

27.4

10.2

92.9

94.2

4.64

412

1170

(3002582) Erythrocytes [#/volume] in Urine

1157

5995

2.64

125.93

5.1

3.1

e6/l

29.1

77.5

3.22

899

4594

(3002032) Base excess in Venous blood by calculation

525

1778

3.43

124.41

6.4

4.2

mmol/l

1.7

1.8

0.06

461

1413

(3021447) Carbon dioxide [Partial pressure] in Venous blood

524

1787

3.40

122.68

6.3

4.2

kpa

5.8

0.21

513

1735

(3012544) pH of Venous blood

532

1839

3.36

121.80

6.5

4.2

7.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2137

15153

3.05

119.09

3.8

3.2

—

(3018095) Leukocytes [#/volume] in Urine

1274

7091

2.52

117.01

6.0

3.6

e6/l

85.5

92.6

0.11

922

4955

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

232

446

5.60

115.92

2.5

1.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

195

317

6.56

115.79

2.2

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

172

245

7.43

115.53

2.2

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

193

319

6.44

112.71

2.5

1.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

374

1089

3.83

110.77

1.6

1.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1787

11822

2.54

109.91

13.3

4.7

mmol/l

7.0

6.7

6.35

1725

11003

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

714

3085

2.79

109.09

3.8

2.9

e6/l

2.1

2.3

0.24

390

1655

(3018677) aPTT in Platelet poor plasma by Coagulation assay

704

3027

2.80

108.50

3.7

2.2

30.6

29.8

2.30

689

2931

(36304419) Bacteria [Presence] in Urine

1037

5393

2.51

108.27

4.8

3.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

154

214

7.58

105.64

2.5

1.8

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1396

8371

2.40

105.23

7.5

4.9

g/l

33.9

36.0

29.57

1329

7810

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

124

133

9.73

104.86

2.3

1.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

164

259

6.68

99.97

2.5

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

274

685

4.34

99.74

2.8

2.6

91.3

91.9

0.16

267

645

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

346

1028

3.72

99.04

24.0

11.1

—

(3018418) pH of Serum or Plasma

1026

5528

2.39

96.67

8.0

4.0

7.4

0.34

250

1084

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

153

233

6.90

96.50

2.2

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

335

997

3.70

95.52

5.7

4.6

mmol/l

24.3

24.0

0.79

327

913

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

716

3292

2.60

95.00

3.7

2.7

e6/l

0.8

1.0

0.95

388

1849

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

161

271

6.26

92.13

2.1

1.4

—

(3036489) Thrombin time

292

811

3.92

91.91

2.8

2.3

21.8

21.4

0.42

273

718

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

703

3346

2.49

85.55

3.0

mmol/l

2.5

2.4

3.58

658

2943

(3024354) Oxygen [Partial pressure] in Venous blood

408

1474

3.09

84.75

5.3

3.6

kpa

5.0

4.7

1.82

395

1429

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

202

451

4.76

84.53

9.5

5.8

iu/ml

1583.2

384.5

0.86

(3005719) IgG [Mass/volume] in Serum or Plasma

426

1589

3.00

83.59

4.7

2.7

g/l

9.4

10.7

5.73

408

1453

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

919

4982

2.29

82.69

4.3

3.0

ng/l

1791.4

1310.9

1.81

821

4183

(40758558) Short blood count panel - Blood

935

5136

2.26

81.22

10.3

6.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1092

6397

2.20

80.78

4.3

3.3

mmol/l

2.3

2.4

11.25

1017

5661

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2068

15605

2.44

80.53

13.7

7.2

u/l

80.8

77.3

2.94

2010

14722

(3017181) Myelocytes/100 leukocytes in Blood

422

1642

2.86

76.25

5.8

4.2

1.0

0.8

0.42

222

458

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

565

2553

2.54

75.82

3.9

2.5

22.3

23.8

1.70

520

2194

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

110

8.82

74.23

2.4

1.6

—

(3000850) Epithelial cells [#/volume] in Urine

785

4141

2.27

73.99

4.4

2.5

e6/l

5.4

5.8

0.38

709

3649

(3022948) Iron [Moles/volume] in Serum or Plasma

623

2975

2.43

73.97

3.9

2.5

umol/l

12.2

13.7

5.45

591

2759

(3012501) Base excess in Blood by calculation

185

428

4.57

73.95

7.5

4.0

mmol/l

2.5

2.4

0.17

131

275

(3004789) Transferrin [Mass/volume] in Serum or Plasma

585

2737

2.46

72.52

3.9

2.5

g/l

2.2

2.3

3.24

556

2538

(3021440) Promyelocytes/100 leukocytes in Blood

401

1563

2.84

71.98

5.9

4.3

0.1

0.66

214

424

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

165

359

4.83

71.08

2.0

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

162

350

4.86

70.37

4.7

3.3

u/ml

281.0

1719.7

—

(3026782) Osmolality of Urine

736

3859

2.25

69.79

4.0

2.7

mosm/kgh2o

534.6

558.4

2.10

656

3289

(3042936) Bacteria identified in Isolate by Culture

591

2831

2.40

69.19

2.8

2.0

—

(3032080) INR in Blood by Coagulation assay

1209

7700

2.04

68.57

12.6

8.6

inr

1.2

0.93

398

2287

(3010421) pH of Blood

197

517

4.03

66.65

7.6

3.8

7.4

0.61

182

421

(3004809) Band form neutrophils/100 leukocytes in Blood

143

293

5.10

66.06

4.5

3.7

1.0

1.3

0.63

105

241

(3002179) Metamyelocytes/100 leukocytes in Blood

378

1499

2.77

65.32

5.5

4.1

0.6

0.47

167

338

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

8.84

63.46

2.6

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

8.84

63.46

2.6

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

200

551

3.84

63.15

3.1

2.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

151

6.77

62.18

3.1

3.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

140

7.00

61.61

2.6

1.6

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1783

13335

2.01

60.91

6.3

4.1

e6/l

225.1

1440.6

1.79

184

(3025159) Blasts/100 leukocytes in Blood

366

1480

2.71

60.67

5.8

4.3

0.0

0.3

0.71

179

361

(3027945) Reticulocytes/100 erythrocytes in Blood

464

2107

2.45

60.44

4.4

2.8

1.9

1.7

1.33

429

1884

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

344

1352

2.77

60.24

2.0

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

323

1243

2.82

58.82

3.3

1.8

g/l

1.4

1.3

0.20

301

1150

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

154

370

4.36

58.53

1.5

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

154

370

4.36

58.53

1.5

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

421

1887

2.46

56.14

3.3

2.5

u/l

37.2

64.4

0.55

364

1617

(3044640) Blood type and Crossmatch panel - Blood

1003

6340

1.93

54.80

3.5

2.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1847

14237

1.96

54.56

6.1

4.0

—

(3022313) Gas panel - Capillary blood

257

908

3.03

54.55

5.9

4.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

494

2408

2.29

54.29

2.2

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

244

843

3.08

53.83

2.6

1.8

g/l

1.6

1.5

0.59

215

732

(3026008) Bacteria identified in Urine by Culture

888

5432

1.95

53.16

3.7

2.8

—

(3023520) Reticulocytes [#/volume] in Blood

357

1525

2.55

52.56

3.9

2.8

e9/l

70.9

70.2

0.13

237

1153

(3040151) Glucose [Moles/volume] in Capillary blood

108

214

5.22

51.77

67.3

8.0

mmol/l

7.1

7.3

0.29

186

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

922

5753

1.92

51.71

2.9

2.1

u/l

321.1

247.9

0.44

884

5420

(3023419) Bacteria identified in Sputum by Culture

103

197

5.40

51.36

3.2

2.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

107

7.28

51.34

44.4

35.9

ug/l

7.5

7.3

0.31

(44790047)

112

231

5.02

51.28

2.3

1.5

—

(44790049)

112

231

5.02

51.28

2.3

1.5

—

(44790048)

112

231

5.02

51.28

2.3

1.5

—

(44806118)

112

231

5.02

51.28

2.3

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

343

1456

2.56

51.10

3.8

2.7

g/l

64.9

66.8

4.06

318

1340

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1052

6931

1.85

49.22

4.3

3.2

u/l

41.1

35.5

0.25

1011

6573

(3019060) Gas panel - Arterial blood

297

1207

2.64

48.27

6.4

5.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

186

5.37

48.22

2.2

1.9

—

(3000492) Spirometry study

428

2101

2.23

45.64

1.8

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

100

207

4.98

45.58

2.2

1.8

—

(3024928) Oxygen saturation in Venous blood

149

426

3.65

44.41

5.0

3.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

178

5.20

43.22

3.5

3.8

64.4

54.1

2.63

126

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

782

4850

1.87

43.16

3.4

2.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

272

1128

2.57

42.23

6.0

3.4

g/l

125.9

130.7

2.59

266

1102

(4010399)

298

1294

2.47

41.96

1.5

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

792

4968

1.84

41.94

2.2

2.0

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

221

836

2.79

41.14

2.0

1.5

u/ml

13.0

15.2

—

(3000494) Fungus identified in Specimen by Culture

452

2361

2.10

40.82

1.9

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

8.79

40.56

1.9

1.6

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

784

4959

1.82

40.08

2.7

2.1

mg/l

3.0

2.8

0.90

688

4225

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

188

662

2.98

39.90

3.2

2.3

ug/l

1700.3

420.7

0.51

183

626

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

170

567

3.13

39.64

2.3

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1048

7245

1.73

39.26

5.6

3.3

ng/l

272.7

55.1

0.59

745

4667

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1147

8135

1.72

39.12

3.0

2.2

nmol/l

71.9

75.0

3.42

1059

7397

(3026493) Urate [Moles/volume] in Serum or Plasma

813

5235

1.79

38.96

4.4

2.6

umol/l

2710.9

4814.7

0.94

739

4612

(3004588) Protein electrophoresis panel - Serum or Plasma

274

1188

2.46

38.60

3.6

2.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

132

5.58

37.58

1.5

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1091

7724

1.70

36.80

2.2

1.9

pmol/l

92.3

95.2

1.28

598

4169

(3042733) HLA Ab [Presence] in Serum

7.09

36.48

4.7

4.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

378

1927

2.12

36.09

2.4

2.1

nmol/l

343.8

374.2

1.91

351

1776

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

156

5.05

35.99

2.0

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

156

5.05

35.99

2.0

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

156

5.05

35.99

2.0

1.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2412

21437

2.28

35.76

32.6

12.5

mg/l

31.5

23.4

26.38

2231

16693

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

154

518

3.09

35.37

4.6

3.6

ratio

14.5

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

392

2043

2.08

35.25

5.2

3.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

145

472

3.19

35.20

1.7

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

367

1873

2.11

34.87

1.6

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

509

2918

1.92

34.86

2.0

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

155

532

3.03

34.37

5.0

3.6

mg/l

53.7

71.9

0.63

114

432

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

155

532

3.03

34.37

5.0

3.6

mg/l

52.4

68.9

0.27

114

432

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

179

669

2.80

34.00

2.0

1.5

titre

490.0

278.3

—

(3002385) Erythrocyte distribution width [Ratio]

2124

18174

1.82

33.55

35.6

15.2

13.9

13.5

12.97

2108

17774

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

8.39

33.00

1.3

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

136

443

3.18

32.97

1.7

1.5

u/ml

124.2

113.2

0.42

(3013707) Erythrocyte sedimentation rate by Westergren method

1841

15180

1.68

32.68

6.1

3.8

mm/h

15.6

10.8

24.46

1768

14093

(3027273) Bicarbonate [Moles/volume] in Venous blood

207

850

2.56

32.61

7.0

3.4

mmol/l

25.2

25.1

0.13

201

819

(3007164) IgA [Mass/volume] in Serum or Plasma

678

4327

1.76

32.50

2.2

1.5

g/l

2.4

2.3

0.05

458

2717

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1282

9672

1.63

32.38

5.0

4.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

735

4804

1.73

32.35

7.4

4.3

—

(40768446) Kidney Pathology biopsy report

6.24

31.81

2.1

1.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

173

659

2.74

31.67

2.1

2.4

g/l

3.7

3.8

0.84

134

486

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

173

659

2.74

31.67

2.1

2.4

g/l

7.6

7.3

0.80

139

505

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

173

659

2.74

31.67

2.1

2.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

157

569

2.87

31.57

3.1

2.6

g/l

0.7

1.1

0.71

131

503

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

23.19

31.48

1.6

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

10.75

31.35

3.5

2.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

148

522

2.94

31.26

1.6

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

143

495

3.00

31.23

1.4

1.3

u/ml

254.5

253.7

0.01

308

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

415

2302

1.95

31.06

4.2

2.9

umol/l

7.0

8.2

0.89

364

2005

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

146

514

2.95

30.94

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

308

1537

2.13

30.85

8.1

3.7

mmol/l

1.2

6.17

294

1330

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

164

619

2.76

30.55

2.1

2.5

g/l

9.7

10.3

0.98

146

529

(3035350) Ketones [Presence] in Urine by Test strip

1319

10130

1.60

30.14

4.9

3.3

estimate

0.0

0.80

286

1911

(3011412) CD3 cells [#/volume] in Blood

211

4.08

30.07

2.6

2.4

e9/l

1.0

1.3

1.77

123

(3009261) Glucose [Presence] in Urine by Test strip

1330

10246

1.59

29.92

4.9

3.3

estimate

0.0

0.80

275

1871

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

154

4.64

29.70

2.2

2.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

177

705

2.62

29.65

2.9

1.8

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2254

19855

1.86

29.59

28.8

11.5

ml/min/173m2

84.0

85.6

2.03

1919

16228

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

159

601

2.75

29.53

6.2

4.9

mg/l

1.9

1.4

5.93

153

561

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

162

619

2.72

29.46

2.1

2.5

g/l

3.2

3.1

0.94

138

494

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

190

786

2.53

29.44

1.5

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

188

775

2.53

29.34

3.2

1.9

—

(3019977) pH of Arterial blood

103

5.53

29.15

2.5

2.9

7.4

0.32

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

129

438

3.04

29.14

1.7

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

1314

10142

1.58

28.96

6.8

4.5

estimate

0.0

0.50

293

1967

(3011397) Hemoglobin [Presence] in Urine by Test strip

696

4599

1.69

28.91

4.0

3.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

103

308

3.44

28.66

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

305

1565

2.07

28.29

2.8

2.3

ug/l

12.0

7.1

1.51

262

1392

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

165

4.39

28.15

2.1

11.7

11.6

0.00

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

618

3980

1.72

28.11

2.0

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

663

4355

1.69

28.02

1.7

1.5

nmol/l

19.6

20.3

0.65

608

3757

(3024980) IgG subclass 4 [Mass/volume] in Serum

106

332

3.28

27.41

1.4

1.8

g/l

0.5

0.8

2.69

259

(3037522) Nuclear Ab [Titer] in Serum

463

2765

1.82

27.27

1.5

1.3

titre

514.4

493.2

0.08

100

547

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

7.24

27.14

2.4

2.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

5.50

26.97

1.4

1.2

u/l

110.8

86.6

0.82

(3019550) Sodium [Moles/volume] in Serum or Plasma

2382

21508

1.99

26.93

36.5

14.2

mmol/l

139.2

139.6

17.81

2355

20947

(3022217) INR in Platelet poor plasma by Coagulation assay

396

2265

1.88

26.75

24.6

23.3

inr

1.4

1.3

0.38

331

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

288

1477

2.06

26.70

3.7

2.7

ng/l

233.9

178.8

1.10

262

1338

(3042631) Mycobacterium sp identified in Specimen

227

3.74

26.41

3.0

2.8

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

193

847

2.38

26.26

1.4

1.3

—

(3045142) Bone marrow Pathology biopsy report

216

3.79

25.93

1.5

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

216

3.79

25.93

5.2

4.3

—

(4062490)

194

3.95

25.82

1.2

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

5.46

25.73

1.9

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

5.46

25.73

1.9

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

5.46

25.73

1.9

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

5.46

25.73

1.9

2.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2382

21585

1.95

25.49

37.2

14.3

mmol/l

4.0

0.08

2353

20985

(3010375) cycloSPORINE [Mass/volume] in Blood

105

5.13

25.44

34.4

26.2

ug/l

128.5

121.0

0.28

(3024139) IgG subclass 3 [Mass/volume] in Serum

192

3.94

25.37

1.2

1.3

g/l

0.4

0.10

133

(3027135) IgG subclass 1 [Mass/volume] in Serum

192

3.94

25.37

1.2

1.3

g/l

6.5

6.8

0.21

134

(3028192) IgG subclass 2 [Mass/volume] in Serum

193

3.91

25.19

1.2

1.3

g/l

2.7

3.1

0.71

134

(21494814) CD8 cells/100 lymphocytes in Specimen

6.03

25.14

2.2

2.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

331

1840

1.91

24.28

2.7

2.3

g/l

0.2

0.03

306

1728

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

5.29

23.91

1.3

1.2

u/l

38.8

16.4

2.25

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

243

3.49

23.89

7.6

6.4

mg/l

11.6

11.4

0.16

226

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

858

6208

1.56

23.77

3.6

2.5

u/l

53.5

57.5

2.83

800

5746

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

132

509

2.68

23.58

2.2

2.4

g/l

0.0

0.34

125

470

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

134

522

2.65

23.46

2.2

2.4

g/l

36.3

37.8

1.68

122

458

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

263

1370

2.02

23.26

7.0

4.2

ng/l

113.4

88.6

2.75

236

1215

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

168

4.00

23.25

1.3

1.2

u/l

70.9

62.1

0.42

119

(40760888) Immunoglobulin light chains.free panel - Serum

112

400

2.88

23.14

5.9

3.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1758

14869

1.53

23.11

4.1

3.0

u/l

50.6

46.9

1.30

1679

14029

(3005322) IgE [Units/volume] in Serum or Plasma

251

1314

2.00

21.86

1.5

1.3

u/ml

191.7

219.6

0.29

230

1209

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

123

477

2.65

21.73

2.3

2.5

g/l

0.0

0.00

116

441

(3024891) Influenza virus A+B Ag [Presence] in Specimen

142

593

2.47

21.54

1.3

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

2262

20410

1.70

21.42

32.6

13.3

39.4

40.5

9.17

1780

15533

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

7.57

21.23

6.0

6.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

128

515

2.56

21.00

1.3

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

121

474

2.63

20.96

2.3

2.5

g/l

0.0

0.00

116

440

(3003434) Protein [Mass/volume] in Pleural fluid

202

3.53

20.62

1.7

1.5

g/l

30.9

32.4

0.40

180

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

167

3.78

20.21

1.4

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

212

3.41

19.86

1.2

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

789

5793

1.51

19.66

5.3

4.1

mg/mmol

17.4

12.2

0.72

534

3757

(3037756) Immunofixation for Serum or Plasma

357

2.81

19.55

2.0

1.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

102

380

2.75

19.51

1.8

1.7

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

105

401

2.68

19.15

4.3

3.6

e9/l

4.2

4.0

0.25

105

401

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

10.58

19.12

2.8

2.3

—

(3044889) 12 lead EKG panel

1666

14192

1.46

19.09

4.5

3.5

—

(3013512) EKG study

741

5404

1.51

18.94

5.1

3.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

107

415

2.64

18.93

5.0

3.9

58.4

56.7

0.62

107

415

(3024932) HLA-DR beta [Type]

5.13

18.36

1.1

—

(4035726)

282

1628

1.82

18.17

1.7

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

343

2.77

18.15

1.2

1.1

—

(3024471) HLA-A [Type]

5.06

18.09

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

143

3.83

18.06

1.2

1.3

u/ml

2.0

0.6

0.35

(3009508) Creatinine [Moles/volume] in Urine

828

6239

1.47

17.81

4.3

3.3

mmol/l

7.5

8.1

2.77

702

5290

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

270

2.98

17.71

1.4

1.2

—

(3012441) Differential panel - Pleural fluid

165

3.57

17.50

1.8

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

139

3.80

17.17

1.7

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

348

2.70

17.12

1.5

1.2

u/ml

2.3

4.0

0.97

118

(3017569) Oxygen content in Arterial blood

4.60

17.04

1.9

2.6

—

(3012516) Albumin [Mass/volume] in Urine

742

5526

1.47

16.74

4.3

3.3

mg/l

326.5

326.1

0.00

518

3607

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

175

3.42

16.72

2.5

2.3

e6/l

739.3

705.6

0.12

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

342

2.69

16.60

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

265

2.92

16.47

1.1

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

104

4.19

16.28

1.6

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

104

4.19

16.28

1.6

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

488

3350

1.56

16.15

2.0

1.7

nmol/l

1113.9

1162.6

0.52

384

2543

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2122

19196

1.51

16.12

5.2

4.4

mu/l

1.9

2.0

0.86

1994

17738

(3023183) Ammonium ion [Moles/volume] in Plasma

106

443

2.45

16.10

4.2

3.1

umol/l

32.8

36.2

0.64

385

(3014148) Varicella zoster virus Ab [Titer] in Serum

319

2.72

16.07

1.1

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

4.98

15.94

3.7

4.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.52

15.88

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

121

541

2.30

15.79

2.4

2.1

mg/l

10.9

11.0

0.07

115

504

(3011648) Oxygen content in Venous blood

177

3.33

15.74

3.6

4.0

10.6

11.5

0.83

177

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

213

3.10

15.70

1.2

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

280

2.80

15.47

2.3

2.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

179

3.29

15.46

1.2

titre

167.5

265.5

0.37

(3052851) Hemolysis interference index of Serum or Plasma

122

555

2.26

15.29

3.7

3.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

4.32

15.01

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

4.97

14.99

1.5

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

389

2.47

14.60

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

5.82

14.46

2.5

1.1

93.6

91.3

0.10

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

5.82

14.46

2.5

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

148

744

2.05

14.40

8.8

5.8

0.8

0.9

2.20

143

697

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

149

754

2.03

14.24

8.7

5.7

1.6

1.7

0.92

143

703

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

348

2.52

14.02

1.6

1.2

u/ml

3.7

4.8

0.43

161

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

7.97

14.02

14.7

7.7

mmol/l

4.8

6.7

1.59

(4268621)

239

2.85

13.98

2.7

2.2

—

(40768806) Pleura Pathology biopsy report

171

3.20

13.84

1.8

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

208

1191

1.81

13.71

12.0

7.4

mmol/l

24.6

24.3

0.42

197

1110

(40761536) Microorganisms panel - Urine sediment

288

1807

1.67

13.71

6.7

3.6

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2422

22762

1.68

13.67

33.3

14.3

umol/l

84.3

77.3

7.68

2422

22753

(3025315) Body weight

11.72

13.53

3.9

3.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

169

3.18

13.44

1.7

1.4

e6/l

55358.3

80858.4

0.22

100

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

235

2.81

13.24

1.3

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

328

2.52

13.21

6.5

3.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.42

13.08

2.3

2.4

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.42

13.08

2.3

2.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

162

3.19

13.02

2.5

2.4

e6/l

479.0

581.9

0.67

136

(3023420) DNA double strand Ab [Units/volume] in Serum

216

2.87

12.92

1.8

1.4

iu/ml

22.4

27.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.36

12.87

2.3

2.4

—

(3004451) EKG impression Narrative

3.89

12.80

1.5

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

376

2.39

12.79

6.5

3.1

mmol/l

1.5

0.06

368

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.91

12.53

7.1

3.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

162

885

1.88

12.41

2.5

1.9

u/l

35.3

38.8

1.37

146

798

(40768804) Tissue Pathology biopsy report

976

7960

1.36

12.20

2.3

2.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

191

2.92

12.08

1.7

1.4

e6/l

1963.7

1714.7

0.23

136

(3045788) Cell count panel - Pleural fluid

150

3.17

11.93

1.8

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

193

2.89

11.87

1.5

1.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2419

22852

1.62

11.81

18.2

9.5

u/l

32.6

27.8

6.57

2378

22135

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

112

3.52

11.69

2.0

1.5

u/l

4.4

7.1

0.45

(40768797) Stomach Pathology biopsy report

383

2663

1.51

11.68

1.3

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

592

4484

1.41

11.53

1.7

1.6

—

(3038515) Glucose [Moles/volume] in Venous blood

350

2.36

11.51

6.9

3.2

mmol/l

7.7

7.4

0.36

344

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

132

692

1.95

11.46

1.7

1.6

iu/ml

0.2

0.3

0.31

114

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

244

1543

1.64

11.23

3.2

2.6

ml/min/173m2

57.4

70.0

3.38

587

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

386

2.27

11.21

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

331

2.37

11.08

1.2

1.1

120.1

115.7

0.53

304

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1777

15991

1.33

10.65

4.4

3.7

pmol/l

14.6

14.7

0.34

1670

14617

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

157

2.96

10.46

2.6

2.5

e9/l

0.2

0.35

136

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.50

10.16

1.3

1.8

—

(4306422)

340

2.27

10.02

1.3

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

113

592

1.95

9.86

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

142

2.99

9.73

2.7

31.5

42.0

1.25

(40757373) Influenza virus identified in Isolate

5.31

9.63

2.4

1.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

115

612

1.92

9.59

1.4

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

182

2.72

9.58

1.2

—

(3002256) Pathology report gross observation

350

2484

1.47

9.57

1.3

—

(21494434) Karyotype in Bone marrow

172

2.76

9.45

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

429

2.09

9.39

1.2

1.1

—

(3035880) pH of Pleural fluid

3.51

9.34

1.3

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.65

9.26

3.2

2.6

—

(1002224) Polysomnography panel

164

983

1.71

9.26

1.1

—

(3025941) Bacteria identified in Stool by Culture

192

1202

1.64

9.20

1.4

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

347

2.19

9.15

1.2

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

4.00

9.05

1.5

63.1

59.0

0.17

(3003740) Influenza virus B Ag [Presence] in Specimen

431

2.05

8.91

1.2

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

501

1.97

8.85

1.6

1.5

e6/l

887.6

1264.9

0.22

400

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

501

1.97

8.85

1.5

e6/l

33.9

35.5

0.02

385

(40768795) Lymph node Pathology biopsy report

184

2.64

8.85

1.6

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.13

8.71

2.9

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.81

8.51

1.2

1.3

106.7

91.9

1.07

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

118

662

1.82

8.39

2.0

1.8

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

105

568

1.88

8.38

1.5

1.4

mg/l

832.8

529.2

0.59

536

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

663

5341

1.32

8.37

1.9

1.6

mmol/l

1.7

1.4

7.13

587

4533

(3008536) Aspergillus sp Ab [Presence] in Serum

4.66

8.35

2.1

2.5

—

(3003338) MCHC [Mass/volume]

2040

18966

1.32

8.26

34.9

15.7

g/l

331.6

333.7

19.06

2034

18811

(40761511) CBC panel - Blood by Automated count

2369

22549

1.44

8.24

23.3

11.7

—

(3048689) Calprotectin [Mass/mass] in Stool

368

2708

1.42

8.24

2.7

2.6

ug/g

161.9

124.6

1.01

296

2151

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2036

18933

1.32

8.17

6.9

5.2

mmol/mol

40.7

39.3

7.10

1940

17719

(3044290) Cell count panel - Cerebral spinal fluid

467

1.96

8.13

1.4

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

312

2.18

8.08

2.1

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

3.25

8.07

1.3

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.77

8.07

1.5

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

22.08

8.01

1.2

1.0

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

7.09

7.99

1.7

1.4

mg/l

0.9

2.6

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

7.09

7.99

1.7

1.4

mg/l

3.9

3.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.89

7.99

1.6

1.0

—

(3020891) Body temperature

126

732

1.76

7.99

7.8

4.6

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

160

2.65

7.88

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

160

2.65

7.88

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

160

2.65

7.88

1.3

1.1

—

(3004775) Volume in Urine collected for unspecified duration

161

2.63

7.78

2.9

2.5

715.8

638.2

0.43

112

(3000060) B lymphocytes [#/volume] in Blood

3.44

7.67

1.8

2.1

e6/l

188.0

268.4

0.40

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

6.69

7.60

1.7

1.4

mg/l

6.3

1.7

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

163

2.60

7.60

1.3

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

124

729

1.74

7.56

1.9

1.7

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

5.62

7.54

1.5

1.8

14.9

6.8

—

(3009871) Measles virus Ab [Titer] in Serum

3.40

7.52

1.3

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.55

7.42

1.0

102.2

91.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

208

2.38

7.37

3.5

2.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

265

2.22

7.36

1.3

nmol/l

0.1

0.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

115

672

1.74

7.17

6.5

4.1

mmol/l

1.3

1.4

0.88

109

661

(3002621) Streptococcal DNAse B [Units/volume] in Serum

6.90

7.15

1.0

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

417

3207

1.36

7.11

1.3

1.2

u/ml

19.5

10.9

0.90

144

1296

(3034426) Prothrombin time (PT)

3.36

7.10

1.5

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

163

2.54

7.09

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

163

2.54

7.09

1.2

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

439

3406

1.35

7.06

1.3

iu/ml

44.6

29.3

1.28

135

1040

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

323

2.07

7.06

1.3

1.2

u/l

53.8

42.0

0.21

279

(3047181) Lactate [Moles/volume] in Blood

106

608

1.77

7.05

9.9

6.5

mmol/l

1.5

1.3

0.62

528

(3029634) Reagin Ab [Titer] in Serum by VDRL

385

1.98

7.04

2.4

2.0

—

4.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

691

5715

1.28

6.97

5.2

3.0

—

(3000330) Specific gravity of Urine by Test strip

146

919

1.62

6.90

4.7

3.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

246

1738

1.46

6.86

3.6

4.3

ug/l

5.0

19.2

2.05

194

1413

(21494890) Protein electrophoresis panel - 24 hour Urine

184

2.41

6.86

1.8

2.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

242

2.21

6.77

1.4

1.3

—

(3003694) ABO and Rh group [Type] in Blood

753

6316

1.27

6.74

1.6

1.5

—

(3047189) Immunofixation for 24 hour Urine

3.15

6.71

1.8

1.7

—

(3023410) Appearance of Cerebral spinal fluid

230

2.24

6.71

1.3

1.8

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

457

1.87

6.65

5.1

2.0

nmol/l

0.9

0.8

0.78

392

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

5.74

6.58

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.17

6.55

1.6

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.17

6.55

1.6

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.17

6.55

1.6

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

460

1.85

6.53

3.3

2.6

ug/min

175.0

123.2

0.37

293

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

597

4894

1.28

6.39

1.3

u/ml

1.0

1.6

2.01

140

1292

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

136

2.59

6.37

2.1

1.1

—

(3007461) Platelets [#/volume] in Blood

2506

24273

1.52

6.37

41.6

18.3

e9/l

251.9

249.9

0.70

2460

23691

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.35

6.27

3.0

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.35

6.27

3.0

2.4

—

(3035941) MCH [Entitic mass]

2507

24295

1.51

6.24

41.4

18.2

30.1

30.3

4.00

2495

23979

(3010813) Leukocytes [#/volume] in Blood

2508

24307

1.52

6.23

41.7

18.3

e9/l

7.4

6.7

10.71

2457

23672

(3024731) MCV [Entitic volume]

2507

24297

1.51

6.21

41.4

18.2

90.7

90.5

1.07

2495

23984

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

180

1220

1.51

6.19

3.7

3.5

pmol/l

4.3

4.6

2.40

163

1083

(3007566) Smooth muscle Ab [Titer] in Serum

100

587

1.73

6.19

1.2

1.3

titre

131.3

71.5

—

(3026361) Erythrocytes [#/volume] in Blood

2507

24300

1.51

6.17

41.5

18.3

e12/l

4.5

4.6

16.51

2457

23669

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

506

1.79

6.15

1.4

mmol/l

4.0

3.7

0.96

473

(3016750) Collection duration of Urine

128

2.60

6.04

3.1

2.4

min

484.9

502.1

0.31

(3000963) Hemoglobin [Mass/volume] in Blood

2507

24311

1.50

6.03

41.9

18.4

g/l

132.8

137.5

41.04

2495

23990

(3016018) Differential panel - Cerebral spinal fluid

241

2.14

6.02

1.3

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.53

5.98

2.1

1.5

—

(36660697) Celiac disease serology panel - Serum

242

1750

1.42

5.97

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.27

5.95

2.5

2.9

—

(3051611) Lipemic interference index of Serum or Plasma

178

2.32

5.93

4.7

3.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

243

2.12

5.90

1.7

1.5

—

(3051651) Icteric interference index of Serum or Plasma

118

2.65

5.89

5.1

3.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

123

775

1.62

5.84

1.3

miu/ml

133.6

234.9

3.43

347

(3000012) Reticulocyte production index

2.88

5.78

2.5

1.8

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

4.66

5.73

1.1

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

304

1.96

5.55

3.4

3.1

nmol/l

0.9

0.8

0.19

238

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

4.50

5.51

2.8

3.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.50

5.51

1.8

2.8

—

(3022621) pH of Urine by Test strip

186

1302

1.46

5.48

3.4

2.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.15

5.46

3.3

2.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

443

1.78

5.45

5.6

4.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

231

2.10

5.44

1.3

nmol/l

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

173

2.27

5.40

3.9

2.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

505

1.73

5.36

1.3

1.2

u/ml

3.2

2.5

—

(3022145) Colonoscopy Study observation

293

2229

1.35

5.33

1.4

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

608

1.65

5.23

2.4

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

509

1.71

5.22

1.3

1.2

u/ml

7.5

6.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.57

5.04

1.3

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

432

1.76

5.02

1.8

1.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

2.64

4.98

3.4

1.7

umol/l

2.2

1.9

0.64

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.67

4.92

1.1

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

520

1.68

4.85

3.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

101

2.59

4.80

1.7

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

250

1.98

4.79

2.1

1.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

9.03

4.78

2.4

4.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

184

1330

1.41

4.59

1.3

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

247

1.96

4.59

2.1

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

122

2.39

4.56

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

154

2.22

4.53

2.5

2.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

371

1.77

4.52

1.2

1.1

iu/ml

20.0

128.3

2.33

107

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

118

787

1.52

4.45

1.7

1.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

100

2.51

4.38

1.7

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

7.52

4.35

3.7

3.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2108

20125

1.22

4.34

4.9

4.1

mmol/l

6.1

5.9

8.61

1998

18507

(4015189)

3.51

4.33

4.1

1.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

332

1.79

4.32

1.2

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

249

1.90

4.16

2.1

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

109

2.40

4.14

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

187

2.05

4.14

1.1

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

575

1.58

4.13

1.4

ug/g

268.4

287.0

0.38

326

(3021788) Differential panel - Synovial fluid

353

1.75

4.08

1.7

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

129

2.26

4.06

1.5

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.45

3.98

4.9

5.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

573

1.57

3.97

7.8

4.3

mmol/l

3.9

0.47

528

(3011985) Renin [Units/volume] in Plasma

247

1.88

3.93

1.4

mu/l

55.0

53.5

0.03

218

(3009466) Valproate [Moles/volume] in Serum or Plasma

343

1.74

3.90

6.3

5.5

umol/l

400.8

373.1

0.83

297

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

4.18

3.88

2.5

1.7

ng/l

102.4

139.9

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.51

3.88

1.0

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.29

3.86

2.9

4.8

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

7.29

3.86

2.9

5.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

330

1.74

3.83

1.2

—

(3011288) Drugs identified in Urine by Screen method

122

848

1.46

3.81

3.4

3.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.61

3.80

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

12.02

3.76

1.8

9.4

—

(3037121) Protein [Mass/volume] in Urine

106

722

1.49

3.68

4.2

3.4

g/l

0.7

0.3

0.68

335

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.68

3.67

1.3

1.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

3.44

3.62

1.1

1.2

titre

—

225.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

212

1.90

3.58

1.1

1.0

—

(3036603) Volume of Urine

130

2.17

3.57

1.6

1.5

2245.6

1937.8

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

124

2.19

3.54

1.7

1.9

—

(3003181) Sodium [Moles/volume] in Urine

301

1.74

3.52

2.2

1.4

mmol/l

73.0

67.5

0.33

247

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

301

1.74

3.52

1.1

g/l

1.5

0.10

276

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

3.86

3.52

3.0

3.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

139

2.10

3.43

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

139

2.10

3.43

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

238

1.82

3.39

1.4

1.5

pmol/l

258.7

308.0

0.76

182

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.58

3.38

1.7

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.58

3.38

2.2

2.9

umol/l

22.6

30.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

147

2.05

3.36

1.1

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

101

2.29

3.36

2.2

3.3

umol/l

96.8

132.8

0.45

(3006653) Thiamine [Moles/volume] in Blood

114

2.20

3.35

1.3

nmol/l

132.6

143.5

0.67

114

(3025468) Yersinia sp identified in Specimen by Organism specific culture

247

1.79

3.32

2.1

1.4

—

(4034850)

638

0.54

3.31

22.7

8.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.42

3.30

1.8

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.42

3.30

1.8

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

134

975

1.39

3.30

2.3

2.2

—

(3048879) Bone marrow aspiration report

2.93

3.30

2.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

408

1.61

3.28

1.3

1.2

u/ml

63.5

39.9

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

8.59

3.26

12.7

9.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.79

3.25

2.5

2.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

249

1.78

3.24

2.1

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

2.34

3.24

1.2

1.1

u/l

82.8

81.5

0.03

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

2.34

3.24

1.2

1.1

u/l

14.9

21.0

0.53

(3025130) Human papilloma virus identified in Specimen

242

1.79

3.23

2.0

1.8

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

3.17

3.21

1.8

1.5

g/l

673.7

25.8

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

250

1.77

3.20

2.1

1.4

—

(40768441) Liver Pathology biopsy report

150

2.01

3.20

1.7

1.5

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

6.38

3.18

5.1

umol/l

599.9

428.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

507

1.53

3.18

1.6

1.4

—

(3019225) pH of Specimen

231

1834

1.28

3.16

8.5

4.1

—

(3017732) Neutrophils [#/volume] in Blood

183

1408

1.32

3.16

4.1

2.8

e9/l

4.4

4.0

0.97

138

1140

(3024869) Neuronal Ab [Presence] in Serum

3.24

3.05

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

440

1.56

3.04

2.9

2.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

456

1.55

3.04

2.0

1.7

e6/l

20814.8

13066.3

0.25

329

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

167

1.93

3.04

13.8

14.7

nmol/l

891.3

830.8

0.26

159

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

644

1.46

3.03

3.3

3.6

u/ml

12.4

6347.2

0.85

551

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.30

2.99

1.6

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

4.72

2.92

1.0

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

3.34

2.90

1.9

1.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

2.22

2.89

1.1

102.9

94.2

0.38

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

468

4047

1.19

2.88

1.8

1.7

pmol/l

468.6

35647758.0

3.93

406

3414

(40763480) Human metapneumovirus Ag [Presence] in Specimen

6.68

2.87

2.0

1.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

102

2.17

2.86

2.4

2.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.20

2.83

1.1

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.06

2.81

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

128

953

1.36

2.79

1.4

iu/l

20.8

23.3

0.39

793

(3029075) Extractable nuclear Ab panel - Serum

2.47

2.79

1.1

1.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

104

750

1.40

2.75

1.3

1.2

u/ml

1.5

0.8

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

125

2.01

2.70

1.2

1.1

ratio

1.1

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

146

1.93

2.70

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.22

2.67

2.3

4.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

119

2.03

2.66

1.1

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

235

1.71

2.65

1.1

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

113

2.04

2.61

1.1

1.2

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

4.68

2.59

1.4

2.0

mg/l

4.3

4.0

—

(3044941) Cell count panel - Synovial fluid

314

1.60

2.58

1.8

1.5

—

(44806071)

3.61

2.57

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

3.61

2.57

3.1

2.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

7.15

2.55

2.0

2.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

7.15

2.55

1.0

—

(3016879) Cocaine [Presence] in Urine

150

1164

1.31

2.50

2.4

2.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2078

20093

1.15

2.45

4.5

3.7

mmol/l

1.5

1.3

14.49

1971

18683

(3019832) Treponema pallidum Ab [Presence] in Serum

330

2809

1.20

2.43

1.8

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.18

2.41

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.01

2.40

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

701

1.38

2.40

2.4

2.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

862

7905

1.13

2.37

5.5

3.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

484

1.46

2.37

1.4

1.3

—

(40768443) Skin Pathology biopsy report

110

824

1.35

2.35

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

190

2335

0.80

2.33

10.0

6.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

260

1.63

2.33

1.4

1.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

2.32

2.31

1.2

5.4

21.3

—

(3020491) Glucose [Moles/volume] in Blood

148

1.83

2.28

1.4

2.2

mmol/l

9.0

6.7

0.84

101

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

628

0.63

2.23

1.3

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.11

2.22

1.2

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

157

1249

1.27

2.19

2.4

2.1

—

(3014891) Appearance of Pleural fluid

3.34

2.18

1.6

1.7

—

(3045414) Leukocytes [Presence] in Urine

115

879

1.32

2.17

2.4

1.8

—

(3029937) Albumin [Presence] in Urine by Test strip

602

5424

1.14

2.16

6.1

3.6

estimate

0.0

1.28

277

1883

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

166

1.76

2.15

1.6

1.9

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

137

1.83

2.13

1.3

1.1

—

3.8

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

244

2046

1.21

2.12

2.5

2.2

nmol/l

11.4

13.2

3.23

219

1844

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

161

1295

1.26

2.07

1.3

au/ml

41.5

55.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.91

2.07

1.1

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.01

2.07

1.0

—

(3028300) Cannabinoids [Presence] in Urine

157

1260

1.26

2.06

2.4

2.2

—

(3027944) Amphetamines [Presence] in Urine

154

1234

1.26

2.05

2.4

2.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.18

2.04

1.5

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

2.64

2.01

2.4

2.3

—

(3027008) Opiates [Presence] in Urine

156

1256

1.26

2.00

2.4

2.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

217

1.62

1.97

1.7

1.6

60.4

60.0

0.02

141

(3008295) Osmolality of Serum or Plasma

217

1.62

1.97

1.2

1.4

mosm/kgh2o

284.2

283.8

0.03

167

(3010726) Horse dander IgE Ab [Units/volume] in Serum

420

1.44

1.95

1.1

u/ml

6.6

2.3

0.53

106

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

521

1.39

1.95

2.1

2.0

iu/l

3.9

5.3

0.50

192

(3033799) Differential panel - Peritoneal fluid

2.36

1.95

4.0

2.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.36

1.95

1.1

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.55

1.94

2.2

1.6

umol/l

75.8

33.9

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.76

1.93

1.0

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

174

1427

1.23

1.90

2.3

2.4

au/ml

12.1

21.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.06

1.90

1.0

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

188

1.66

1.90

1.3

1.5

promille

1.5

1.2

0.31

152

(3035320) C reactive protein [Mass/volume] in Body fluid

150

1.74

1.90

3.0

2.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

448

1.42

1.89

1.1

u/ml

8.3

6.3

0.32

244

(3051101) Glucose [Moles/volume] in Cord blood

2.86

1.86

2.8

6.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

190

1.64

1.84

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.21

1.84

1.3

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

326

1.48

1.84

1.1

u/ml

14.2

4.9

0.95

136

(4198724)

137

1.76

1.83

2.5

1.9

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

115

1.83

1.82

1.7

1.4

nmol/l

1.0

1.3

0.42

(3019768) Coxiella burnetii Ab [Presence] in Serum

4.17

1.82

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

4.17

1.82

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

125

1561

0.79

1.81

1.6

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

311

1.49

1.80

1.4

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

624

1.34

1.80

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

118

932

1.28

1.80

1.9

1.6

mu/l

331.5

291.3

0.59

107

847

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

3.05

1.80

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.35

1.77

1.3

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

362

1.45

1.77

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

498

1.38

1.75

1.2

1.1

u/ml

2.1

1.7

0.13

201

(3015076) Soybean IgE Ab [Units/volume] in Serum

132

1.75

1.73

1.1

1.0

u/ml

2.0

5.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

217

1839

1.20

1.73

2.1

2.0

—

(3007463) Buprenorphine [Presence] in Urine

3.85

1.71

3.6

5.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.30

1.70

1.5

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

171

1.64

1.70

1.8

1.5

33.5

31.3

0.10

107

(3009214) Lutropin [Units/volume] in Serum or Plasma

771

1.29

1.70

1.5

u/l

7.1

7.9

0.33

626

(3047352) Trisomy 18 risk [Likelihood] in Fetus

562

1.34

1.68

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

203

1.58

1.68

2.5

2.1

nmol/l

16.4

20.4

1.31

192

(3008401) Mugwort IgE Ab [Units/volume] in Serum

434

1.39

1.67

1.1

u/ml

1.7

1.6

0.01

182

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.16

1.66

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

112

1.79

1.64

1.2

1.1

miu/ml

1599.5

1485.2

0.15

112

(3023383) Lactate [Moles/volume] in Pleural fluid

2.25

1.63

1.5

mmol/l

3.0

3.1

0.03

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.58

1.61

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.58

1.61

1.0

—

(3038026) Centromere Ab [Units/volume] in Serum

151

1.66

1.60

1.3

1.1

—

65.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

620

1.32

1.59

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.00

1.58

3.3

9.3

—

(3042517) Benzodiazepines panel - Urine

2.70

1.58

2.4

2.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

175

1.61

1.57

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

448

1.37

1.57

6.6

3.3

mg/l

39.3

26.5

1.28

287

(42529406) Shigella sp [Presence] in Stool by Culture

631

1.31

1.56

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

145

1.66

1.54

1.1

u/ml

0.6

0.9

—

(40761535) Cells panel - Urine sediment

184

1558

1.19

1.51

4.4

3.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.60

1.51

1.7

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

146

1.65

1.50

1.8

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.16

1.50

1.5

1.2

—

(4281824)

162

1.61

1.49

1.3

1.1

—

(3024263) Appearance of Synovial fluid

101

1.79

1.48

1.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

147

1.64

1.47

1.8

1.2

—

(3005033) Fetal Nuchal fold Thickness US

559

1.31

1.45

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.50

1.45

1.1

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.88

1.44

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.88

1.44

1.1

—

(3044007) Cell count panel - Peritoneal fluid

2.12

1.44

2.9

1.9

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

3.13

1.44

1.0

1.1

—

25.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.73

1.43

1.5

1.6

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

188

1.55

1.42

1.9

2.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

345

3088

1.13

1.39

2.2

1.8

1.5

1.4

0.25

303

2771

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2171

21258

1.11

1.39

5.1

4.5

mmol/l

2.7

2.8

2.75

2046

19808

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.42

1.39

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

144

1203

1.21

1.39

1.4

1.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

365

1.38

1.37

2.7

3.5

u/ml

68.2

1062.2

0.81

342

(3002619) Bacteria identified in Specimen by Culture

2.20

1.37

1.1

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

311

0.61

1.36

1.4

1.3

mmol/l

6.3

7.1

1.19

225

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

689

1.27

1.36

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

574

1.30

1.36

1.5

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

2.94

1.36

1.6

1.1

u/ml

4.9

15.9

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.94

1.36

2.0

1.9

—

(4024509)

163

0.49

1.35

1.8

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

141

1179

1.21

1.35

1.5

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

115

942

1.23

1.35

2.1

2.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.15

1.33

1.1

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

128

1.65

1.33

1.1

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

506

1.31

1.32

1.5

1.3

—

(3028717) Thiamine [Mass/volume] in Blood

2.50

1.30

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.10

1.30

2.2

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

464

1.32

1.30

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

1.89

1.28

2.8

2.3

e6/l

287.1

789.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

132

0.45

1.28

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.94

1.27

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

687

1.26

1.27

1.3

1.4

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

2.29

1.26

4.5

11.9

umol/l

0.3

0.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

169

1447

1.18

1.26

1.2

iu/ml

71.5

142.4

3.31

553

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

274

2435

1.14

1.25

1.9

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

207

2368

0.86

1.25

4.6

4.1

32.5

31.5

0.58

150

1667

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

689

1.26

1.25

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

115

1.66

1.24

5.4

7.2

—

(40765096) Chromosome analysis panel by Banding

1.91

1.22

1.1

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.63

1.21

1.0

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.17

1.21

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.17

1.21

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.17

1.21

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.17

1.21

1.0

1.1

—

(21494755) Public health laboratory ask at order entry panel

228

2583

0.87

1.21

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.84

1.19

1.3

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.31

1.18

1.3

—

629.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

165

1.52

1.17

1.2

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

231

1.43

1.17

1.4

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

687

1.25

1.16

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

325

1.36

1.16

2.4

2.3

umol/l

6.8

7.5

0.11

243

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.05

1.15

1.0

1.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.50

1.15

1.2

3.1

u/field

0.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.85

1.13

3.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.82

1.09

1.1

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

204

2309

0.87

1.09

1.9

1.7

—

(3052592) Norovirus Ag [Presence] in Stool

2.19

1.08

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.19

1.08

1.3

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

297

2688

1.12

1.04

1.5

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

138

1185

1.17

1.04

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

2.28

1.03

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

147

1.50

1.00

1.9

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

352

1.31

0.99

1.1

u/ml

9.7

3.8

0.91

141

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

164

1.47

0.99

1.3

1.6

—

(40768793) Breast Pathology biopsy report

378

0.71

0.98

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.18

0.98

1.6

2.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

459

4263

1.09

0.97

2.6

2.8

ug/l

0.7

0.01

320

2652

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.95

0.97

1.0

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.95

0.97

1.4

1.2

—

(40758292) HTLV I+II Ab panel - Serum

1.95

0.97

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.95

0.97

1.9

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

190

1.43

0.96

4.3

5.0

u/ml

148.2

62.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

320

1.32

0.94

1.0

u/ml

1.4

2.1

1.19

150

(3006462) Nitrate [Presence] in Urine

1.65

0.94

2.9

2.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

752

1.20

0.94

1.4

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.15

0.91

1.2

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.15

0.91

1.2

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

118

1.53

0.90

1.4

u/ml

24.8

19.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.75

0.90

1.2

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.07

0.89

1.2

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.07

0.89

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.00

0.87

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

1.67

0.85

1.1

1.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

589

0.79

0.82

1.9

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2129

20966

1.08

0.82

4.6

4.1

mmol/l

4.6

4.7

4.14

2007

19666

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

763

7279

1.07

0.82

4.1

4.5

ug/l

3.0

2.6

0.14

689

6582

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.82

0.79

1.0

1.2

—

(3022689) Creatine [Moles/volume] in Urine

1.67

0.78

1.9

1.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.77

0.76

1.8

1.6

—

(4146454)

200

1.35

0.76

3.4

2.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

515

0.79

0.75

1.3

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.09

0.74

1.2

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

150

1.40

0.73

1.2

1.1

u/ml

9.7

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

666

0.82

0.73

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.00

0.72

1.0

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

2.00

0.72

1.0

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.61

0.72

1.2

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.75

0.71

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.58

0.71

1.2

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

248

1.29

0.68

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.85

0.68

1.6

2.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.64

0.68

1.2

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

320

1.25

0.67

2.0

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

179

1.34

0.66

1.9

1.3

e6/l

94080.5

112891.9

0.09

126

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

146

1.37

0.63

1.4

2.0

u/field

5.4

2.0

0.62

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

163

1476

1.11

0.63

2.0

1.9

—

(40765089) Chromosome analysis panel - Blood by G-banded

103

0.58

0.62

1.0

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.67

0.61

1.0

1.3

—

(3001556) Androgen free Index in Serum or Plasma

1.67

0.61

1.0

1.2

—

(4211845)

1.45

0.59

2.9

2.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

201

1.30

0.59

1.1

1.2

mg/l

41.8

42.9

0.07

165

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.51

0.58

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

309

1.23

0.58

1.1

1.0

u/ml

1.2

0.4

0.32

(40761995) Spermatozoa Progressive [#/volume] in Semen

114

0.61

0.58

1.9

2.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

114

0.61

0.58

3.7

5.9

—

(44806420)

1.48

0.57

3.4

2.5

—

(4027681)

158

1.33

0.57

1.1

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2109

20839

1.06

0.56

4.6

4.0

mmol/l

1.4

12.38

1982

19448

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

362

3427

1.07

0.52

2.3

2.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.41

0.51

1.3

ug/l

6.8

8.7

—

(3000034) Microalbumin [Mass/volume] in Urine

179

0.72

0.50

1.7

3.0

mg/l

15.2

31.8

—

132

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.52

0.48

1.3

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.49

0.47

1.4

1.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

1.41

0.47

1.8

1.5

1.8

4.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.46

0.46

1.9

1.2

30.7

30.9

—

(4094501)

551

1.15

0.46

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

111

1.35

0.46

1.7

2.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

602

1.13

0.43

1.1

u/ml

6.8

4.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.61

0.43

1.0

—

(3000285) Sodium [Moles/volume] in Blood

1.56

0.42

1.4

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3009015) Lactate [Moles/volume] in Synovial fluid

0.00

0.40

0.0

1.4

—

7.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

172

0.75

0.40

1.8

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

961

0.90

0.40

2.7

1.9

—

(44813793)

141

1.28

0.40

1.1

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

215

1.21

0.38

1.9

2.0

mg/l

39.7

23.2

—

(3044927) Protein electrophoresis panel - Urine

188

1.23

0.37

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

152

1.25

0.37

2.5

2.0

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.40

0.35

9.2

1.9

mmol/l

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

298

0.84

0.34

1.6

1.5

—

(37021550) Renin [Units/volume] in Plasma --upright

1.31

0.33

1.2

1.3

mu/l

60.8

72.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

314

3022

1.04

0.29

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.30

0.28

2.0

2.7

—

(3008898) HLA-B27 [Presence]

814

0.92

0.28

1.0

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

205

1.17

0.27

1.3

1.4

mmol/l

12.1

13.1

0.23

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

113

1.24

0.26

1.0

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.68

0.26

1.0

1.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

322

3112

1.04

0.25

2.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.20

0.25

2.3

1.8

—

(3019150) Specific gravity of Urine by Refractometry

456

4444

1.03

0.23

5.2

3.6

kg/l

1.0

0.20

647

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

140

1331

1.05

0.23

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.28

0.23

1.8

3.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

835

1.07

0.22

2.7

2.8

u/ml

23.5

56.4

3.42

805

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

333

1.11

0.22

1.7

1.5

nmol/l

0.3

0.03

272

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.27

0.22

1.1

1.0

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.22

0.22

2.0

1.7

nmol/l

0.3

0.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.22

0.22

1.8

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

116

1.21

0.22

1.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

191

1.15

0.22

1.0

1.1

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

7.9

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

523

0.92

0.21

1.5

1.7

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

109

1034

1.06

0.20

3.1

2.4

u/l

5885.3

5706.4

0.02

414

(3022670) pH of Venous cord blood

0.00

0.20

0.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

326

1.11

0.20

1.2

—

(3017704) Immunofixation for Urine

108

1.20

0.20

1.6

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.18

0.19

1.2

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

146

1.17

0.19

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

872

1.06

0.18

1.2

1.5

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

206

0.87

0.18

1.7

mmol/l

7.1

7.5

—

120

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

893

1.04

0.13

1.6

1.7

mg/l

5.7

4.4

0.33

609

(3006270) Folate [Moles/volume] in Blood

161

1.12

0.13

1.1

nmol/l

402.4

392.6

0.07

147

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

620

0.95

0.12

1.6

1.5

—

(40768800) Prostate Pathology biopsy report

402

0.94

0.10

1.2

—

(3015183) Erythrocyte sedimentation rate

135

1.11

0.09

1.1

1.2

—

(3045424) Erythrocytes [Presence] in Urine

350

1.06

0.09

1.7

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.11

0.09

20.8

7.1

—

(4133840)

1.09

0.08

1.6

1.1

—

(3020650) Glucose [Presence] in Urine

1.04

0.08

1.4

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

459

0.96

0.07

2.4

1.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

244

0.94

0.06

1.3

1.4

pmol/l

61.5

182.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

584

5810

1.01

0.04

3.4

3.8

23.1

21.7

1.11

245

2593

(3005570) Glucose [Moles/volume] in Urine

201

1.05

0.03

2.3

2.1

—

(1761868) Lipid panel - Serum or Plasma

808

8103

1.00

0.03

3.1

2.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

147

0.95

0.01

1.1

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

155

0.97

0.00

1.0

1.1

u/l

0.9

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

4.6

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.7

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.86

0.00

1.4

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.0

2.2

—

1072.3

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

0.00

0.0

1.0

—

152.5

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.4

—

2.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3014271) Vancomycin [Susceptibility]

1.01

0.00

2.2

2.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.99

0.00

1.1

—

(3017400) Magnesium [Moles/volume] in Urine

0.00

0.0

1.0

—

2.7

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

2.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

30.3

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3051593) INR in Capillary blood by Coagulation assay

0.97

0.00

18.3

14.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint VIRALPNEUMONAS and mortality.

Females

Parameter	HR [95% CI]	p-value
VIRALPNEUMONAS	2.255 [1.88, 2.71]	< 0.001
Birth year	1.0 [0.99, 1.01]	0.902

During the follow-up period (1.1.1998 — 31.12.2019), 827 out of 3529 females with VIRALPNEUMONAS died.

Males

Parameter	HR [95% CI]	p-value
VIRALPNEUMONAS	2.692 [2.21, 3.28]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.023

During the follow-up period (1.1.1998 — 31.12.2019), 901 out of 3975 males with VIRALPNEUMONAS died.

Mortality risk

Mortality risk for people of age

years, who have VIRALPNEUMONAS.

N-year risk	Females	Males
1	0.203%	0.548%
5	1.273%	3.523%
10	3.244%	8.66%
15	6.991%	15.832%
20	12.016%	25.6%

Relationships between endpoints

↥

Index endpoint: VIRALPNEUMONAS – Viral pneumonia (unknown virus, not influenza)

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Viral pneumonia (unknown virus, not influenza)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints